CRTH2 and D-Type Prostanoid Receptor Antagonists as Novel Therapeutic Agents for Inflammatory Diseases

Publisher： Karger

E-ISSN： 1423-0313|85|6|372-382

ISSN： 0031-7012

Source： Pharmacology, Vol.85, Iss.6, 2010-06, pp. : 372-382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2

By Yang Longhe   Li Yanting   Ren Jie   Zhu Chenggang   Fu Jin   Lin Donghai   Qiu Yan  

International Journal of Molecular Sciences, Vol. 15, Iss. 8, 2014-08 ,pp. : 13637-13648

MDPI

Access to resources Recommend Favorite

Towards a Novel Class of Multitarget-Directed Ligands: Dual P2X7–NMDA Receptor Antagonists

By Karoutzou Olga   Kwak Seung-Hwa   Lee So-Deok   Martínez-Falguera Daina   Sureda Francesc X.   Vázquez Santiago   Kim Yong-Chul   Barniol-Xicota Marta  

Molecules, Vol. 23, Iss. 1, 2018-01 ,pp. : 230-230

MDPI

Access to resources Recommend Favorite

Altered Inhibitory Function of the E-Type Prostanoid Receptor 4 in Eosinophils and Monocytes from Aspirin-Intolerant Patients

By  

Pharmacology, Vol. 94, Iss. 5-6, 2014-12 ,pp. : 280-286

Karger

Access to resources Recommend Favorite

Modulation of Peripheral Inflammatory Pain Thresholds by M1 and Nicotinic Receptor Antagonists

By  

Pharmacology, Vol. 88, Iss. 5-6, 2011-11 ,pp. : 309-315

Karger

Access to resources Recommend Favorite

Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches

By Park Mi Hee   Hong Jin Tae  

Cells, Vol. 5, Iss. 2, 2016-03 ,pp. : 15-15

MDPI

Access to resources Recommend Favorite